Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-Dermal vs Subcutaneous Insulin in Type 1 Diabetes
NCT00553488Phase 2Completed
- Sponsor
- BD
- Start
- Sep 2007
- Primary completion
- Dec 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of human insulin and insulin lispro in type 1 diabetes mellitus (T1D) (5 arms), sponsored by BD. Primary endpoint: Area Under Curve of blood glucose. Started Sep 2007; status: completed.
02
Drugs
human insulininsulin lispro
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00553488.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00553488.